Author(s):
Lowilius Wiyono, Brenda Cristie Edina, Risya Amelia Rahmawanti, Nurma Nur Azizah, Rafika Indah Paramita, Erni Hernawati Purwaningsih, Fadilah Fadilah
Email(s):
fadilah81@gmail.com
DOI:
10.5958/0974-360X.2020.00497.7 
Address:
Lowilius Wiyono1, Brenda Cristie Edina1, Risya Amelia Rahmawanti1, Nurma Nur Azizah2, Rafika Indah Paramita2, Erni Hernawati Purwaningsih3, Fadilah Fadilah2,4*
1Undergraduate Program, Faculty of Medicine Universitas Indonesia, Salemba Raya No. 6, Jakarta Pusat.
2Departement of Chemistry, Faculty of Medicine Universitas Indonesia, Salemba Raya No. 6, Jakarta Pusat, 10430, Indonesia.
3Department of Farmacy, Faculty of Medicine Universitas Indonesia.
4Biobank Research FKUI-RSCM, Salemba Raya No. 6, Jakarta Pusat, 10430, Indonesia.
*Corresponding Author
Published In:
Volume - 13,
Issue - 6,
Year - 2020
ABSTRACT:
Breast cancer is the 3rd most common cancer in the world and the most common one in women. An alternative pharmacological treatment for breast cancer is needed. Kaempferia pandurata is an endemic plant in Asia which is known for its biological activity, of which is an anticancer activity with its most abundant bioactive compound, pinostrobin. The rhizome of Kaempferia pandurata is dried and extracted using maseration with n-Hexane solvent. The extract then isolated using the recrystallization method in methanol solvent to produce pinostrobin crystal. Pinostrobin is manufactured into nanoparticle using chitosan and sodium alginate polymer, which then analyzed using TEM and UV-Vis test. The pinostrobin and its nanoparticle counterpart are tested in MTT assay to show its inhibitory activity and then analyzed. TEM and UV-Vis test to the nanoparticle of pinostrobin showed the nanoparticle’s dimension of <200 nm with a yield of 99.43%. MTT assay showed good anticancer activity from both pinostrobin and its nanoparticle. Better activity is shown by MDAMB-231 cell, while nanoparticle of pinostrobin showed better activity. The nanoparticle of pinostrobin has been manufactured with a decent yield and dimension. Better anticancer activity is shown in pinostrobin nanoparticle while the anticancer activity of MDAMB-231 cell is superior to MCF-7 cell for both samples. Pinostrobin can be considered as a potential drug for breast cancer.
Cite this article:
Lowilius Wiyono, Brenda Cristie Edina, Risya Amelia Rahmawanti, Nurma Nur Azizah, Rafika Indah Paramita, Erni Hernawati Purwaningsih, Fadilah Fadilah. Isolation, Synthesis Nanoparticle, and In-vitro test of Pinostrobin from Kaempferia pandurata on MCF-7 and MDAMB-231 Breast Cancer Cell. Research J. Pharm. and Tech 2020; 13(6): 2797-2801. doi: 10.5958/0974-360X.2020.00497.7
Cite(Electronic):
Lowilius Wiyono, Brenda Cristie Edina, Risya Amelia Rahmawanti, Nurma Nur Azizah, Rafika Indah Paramita, Erni Hernawati Purwaningsih, Fadilah Fadilah. Isolation, Synthesis Nanoparticle, and In-vitro test of Pinostrobin from Kaempferia pandurata on MCF-7 and MDAMB-231 Breast Cancer Cell. Research J. Pharm. and Tech 2020; 13(6): 2797-2801. doi: 10.5958/0974-360X.2020.00497.7 Available on: https://rjptonline.org/AbstractView.aspx?PID=2020-13-6-47
REFERENCE:
1. Stuckey A. Breast cancer: epidemiology and risk factors. Clin Obstet Gynecol. March 2011; 54 (1): 96-102.
2. Tao Z, et al. Breast cancer: epidemiology and etiology. Cell Biochem Biophys. December 2014; 72 (2): 333-8.
3. InfoDATIN: data and information center Ministry of Health. Jakarta: Ministry of Health of the Republic of Indonesia; 2016. p. 5-8.
4. Devi C, Tang T, Corbex M. Incidence and risk factors for breast cancer in three distinct subtypes south-east asian ethnic group: chinese, malay, and natives of Sarawak, Malaysia. ICJ. March 2012; 131 (12): 2869-77.
5. P. Chalasani Breast Cancer Treatment & Management: Approach Considerations, Treatment of Invasive Breast Cancer, Systemic Adjuvant Therapy for Breast Cancer [Internet]. Emedicine.medscape.com. 2018 [cited 20 January 2018]. Available from: https://emedicine.medscape.com/article/1947145-treatment
6. Kumar P, Kumar S, Baruah C. Breast cancer management. Elsevier. July 2013; 67 (1): 685-6.
7. Chahyadi A, Hartati R, Wirasutisna K, Elfahmi. Boesenbergia pandurata Roxb., An Indonesian medicinal plant: phytochemistry, biological activity, plant biotechnology. Procedia Chemistry. 2014; 13 (2014): 13-37.
8. Le Bail J, Habrioux G, Aubourg L. Effects of pinostrobin on estrogen metabolism and estrogen receptor transactivation. Cancer Letters. 2000; 156 (1): 37-44.
9. Rizvi S, Saleh A. Applications of nanoparticles in drug delivery system technology. Saudi J. Pharm 2018; 26 (1): 64-70.
10. Karamouzis M, Papavassiliou K, Adamopoulos C, Papavassiliou A. Targeting the androgen / estrogen receptors in cancer crosstalk. Trends in Cancer. 2016; 2 (1): 35-48.
11. Tan B, Tan S, Wong S, Ata N, N Rahman, Khalid N. Distribution of flavonoids and cyclohexenyl chalcone derivatives in conventional propagated in vitro-derived and field-grown boesenbergia rotunda (L.) mansf. Evidence-Based Complementary and Alternative Medicine. 2015; 2015 (451 870): 1-7,
12. Jaipecht T, Kanghae S, Pancharoen O, Patrick V, Reutrakul V, Tuntiwachwuttikul P, et al. Constituents of Boesenbergia pandurata (syn. Kaempferia pandurata) isolation, crystal structure and synthesis of-boesenbergia A. Aust. J Chem. 1982; 35: 351-61.
13. Patel N, Jaiswal G, Bhutani K. A review on biological sources, chemistry, and pharmacological activities of pinostrobin. Natural Product Research. 2015; 2015: 110 756.
14. Sukardiman, Charisma D, Plumeriastuti H, Arifianti L. Anticancer effect of pinostrobin from Kaempferia pandurata Roxb. in benzo (a) pyrene-induced fibrosarcoma in mice. E-Journal Planta Husada. 2014; 2 (2): 44-6.
15. Jaudan A, Sharma S, Malek S, Dixit A. Induction of apoptosis by pinostrobin in human cervical cancer cells: possible mechanism of action. PLoS ONE. 2018; 13 (2): e0191523.
16. Oerlemans C, Bult W. Polymeric micelles in anticancer therapy: targeting, imaging, and triggered release. Pharm Res. 2010; 27: 2569-89.
17. Lombardo D, Kiselev M, Caccamo M. Smart nanoparticles for drug delivery application: development of versalite nanocarrier platforms in biotechnology and nanomedicine. Journal of Nanomaterials. 2019; 2019: 3,702,518.
18. Atjanasuppat K, Wongkham W, Meepowpan P, Kittakoop P, Sobhon P, Barlett A, et al. In vitro screening for anthelmintic and antitumour activity of ethnomedical plants from Thailand. J Ethnopharmacol. 2009; 123 (3): 475-82.
19. Wang J, Hu X, Xiang D. nanoparticle drug delivery systems: an excellent carrier for tumor peptide vaccines. Drug Delivery. 2018; 25 (1): 1319-27.
20. K Balakrishnan, Wab HAA, Razak K, S. Shamsuddin In vitro evaluation of cytoxicity of colloidal amorphous silica nanoparticles for drug delivery designed on human cell lines. Journal of Nanomaterials. 2013; 2013 (3): 729 306.
21. Oerlemans C, Bult W. Polymeric micelles in anticancer therapy: targeting, imaging, and triggered release. Pharm Res. 2010; 27: 2569-89.
22. Divya K, Jisha MS. Chitosan nanoparticles preparation and applications. Environmental Chemistry Letters. 2017; 16 (1): 101-12.
23. Mohammed MA, Syeda JT, Wasan K, Wasan E. An overview of chitosan nanoparticles and its applications non-parenteral drug delivery. Pharmaceutics. 2017; 9 (4): 53.
24. Li P, Dai Y, Zhang J, Wang A, Wei Q. chitosan-alginate nanoparticles as a novel drug delivery system for nifedipine. Int J Biomed Sci. 2008; 4 (3): 221-8.
25. Katuwavila N, Perera A, Samarakoon S, Soysa P, V Karunaratne, Amaratunga G. Chitosan-alginate nanoparticle system efficiently deliver doxorubicin to MCF-7 cells. Journal of Nanomaterials. 2016; 2016: 3,178,904.
26. Sosnik A. Alginate particles as a platform for drug delivery by the oral route: state-of-the-art. ISRN Pharm. 2014; 2014: 926 157.
27. Junior WA, Gomes DB, Zanchet B, Schonell AP, Diel K, Banzato TP. Antiproliferative effects of pinostrobin and 5,6-dehydrokavain isolated from leaves of Alpinia zerumbet. JBJP. 2017; 27 (5): 592-8.
28. Fadilah, Edina BC, Rahmawati RA, Wiyono L, Erlina L, Paramita RI, Tejo A. Molecular dynamic of pinostrobin and pinocembrin from Kaempferia pandurata Roxb. towards estrogen receptor positive (ESR) and estrogen receptor negative (VEGFR) of breast cancer. Asian Journal of Pharmaceutics. 2018; 12 (4): S1473-80.